Literature DB >> 23403335

Chronic manifestation of postreperfusion intramyocardial hemorrhage as regional iron deposition: a cardiovascular magnetic resonance study with ex vivo validation.

Avinash Kali1, Andreas Kumar, Ivan Cokic, Richard L Q Tang, Sotirios A Tsaftaris, Matthias G Friedrich, Rohan Dharmakumar.   

Abstract

BACKGROUND: Intramyocardial hemorrhage frequently accompanies large reperfused myocardial infarctions. However, its influence on the makeup and the ensuing effect on the infarcted tissue during the chronic phase remain unexplored. METHODS AND
RESULTS: Patients (n=15; 3 women), recruited after successful percutaneous coronary intervention for first segment-elevation myocardial infarction, underwent cardiovascular magnetic resonance imaging on day 3 and month 6 after percutaneous coronary intervention. Patients with hemorrhagic (Hemo+) infarctions, as determined by T2* cardiovascular magnetic resonance on day 3 (n=11), showed persistent T2* losses colocalized with scar tissue on the follow-up scans, suggesting chronic iron deposition. T2* values of Hemo+ territories were significantly higher than nonhemorrhagic (Hemo-) and remote territories (P<0.001); however, T2* values of nonhemorrhagic (Hemo-) and remote territories were not different (P=0.51). Canines (n=20) subjected to ischemia-reperfusion injury (n=14) underwent cardiovascular magnetic resonance on days 3 and 56 after ischemia-reperfusion injury. Similarly, sham-operated animals (Shams; n=3) were imaged using cardiovascular magnetic resonance at similar time points. Subsequently, hearts were explanted and imaged ex vivo, and samples of Hemo+, Hemo-, remote, and Sham myocardium were isolated and stained. The extent of iron deposition ([Fe]) within each sample was measured using mass spectrometry. Hemo+ infarcts showed significant T2* losses compared with the other (control) groups (P<0.001), and Perls stain confirmed localized iron deposition. Mean [Fe] of Hemo+ was nearly an order of magnitude greater than that of the control groups (P<0.001), but no significant differences were observed among the control groups. A strong linear relationship was observed between log(T2*) and -log([Fe]); R(2)=0.7 and P<0.001. The monoclonal antibody Mac387 stains, along with Perls stains, showed preferential localization of newly recruited macrophages at the site of chronic iron deposition.
CONCLUSIONS: Hemorrhagic myocardial infarction can lead to iron depositions within the infarct zones, which can be a source of prolonged inflammatory burden in the chronic phase of myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23403335     DOI: 10.1161/CIRCIMAGING.112.000133

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  36 in total

1.  Determination of location, size, and transmurality of chronic myocardial infarction without exogenous contrast media by using cardiac magnetic resonance imaging at 3 T.

Authors:  Avinash Kali; Ivan Cokic; Richard L Q Tang; Hsin-Jung Yang; Behzad Sharif; Eduardo Marbán; Debiao Li; Daniel S Berman; Rohan Dharmakumar
Journal:  Circ Cardiovasc Imaging       Date:  2014-03-28       Impact factor: 7.792

Review 2.  Recent Advances in Cardiovascular Magnetic Resonance: Techniques and Applications.

Authors:  Michael Salerno; Behzad Sharif; Håkan Arheden; Andreas Kumar; Leon Axel; Debiao Li; Stefan Neubauer
Journal:  Circ Cardiovasc Imaging       Date:  2017-06       Impact factor: 7.792

Review 3.  Intramyocardial haemorrhage after acute myocardial infarction.

Authors:  Ryanne P Betgem; Guus A de Waard; Robin Nijveldt; Aernout M Beek; Javier Escaned; Niels van Royen
Journal:  Nat Rev Cardiol       Date:  2014-11-18       Impact factor: 32.419

4.  Persistent Microvascular Obstruction After Myocardial Infarction Culminates in the Confluence of Ferric Iron Oxide Crystals, Proinflammatory Burden, and Adverse Remodeling.

Authors:  Avinash Kali; Ivan Cokic; Richard Tang; Alice Dohnalkova; Libor Kovarik; Hsin-Jung Yang; Andreas Kumar; Frank S Prato; John C Wood; David Underhill; Eduardo Marbán; Rohan Dharmakumar
Journal:  Circ Cardiovasc Imaging       Date:  2016-11       Impact factor: 7.792

5.  Iron-Sensitive Cardiac Magnetic Resonance Imaging for Prediction of Ventricular Arrhythmia Risk in Patients With Chronic Myocardial Infarction: Early Evidence.

Authors:  Ivan Cokic; Avinash Kali; Hsin-Jung Yang; Raymond Yee; Richard Tang; Mourad Tighiouart; Xunzhang Wang; Warren S Jackman; Sumeet S Chugh; James A White; Rohan Dharmakumar
Journal:  Circ Cardiovasc Imaging       Date:  2015-08       Impact factor: 7.792

6.  Magnetic resonance imaging of infarct-induced canonical wingless/integrated (Wnt)/β-catenin/T-cell factor pathway activation, in vivo.

Authors:  Marco Matteucci; Valentina Casieri; Khatia Gabisonia; Giovanni Donato Aquaro; Silvia Agostini; Giuseppe Pollio; Daniela Diamanti; Marco Rossi; Massimiliano Travagli; Valentina Porcari; Fabio A Recchia; Vincenzo Lionetti
Journal:  Cardiovasc Res       Date:  2016-09-26       Impact factor: 10.787

7.  Colors of Myocardial Infarction: Can They Predict the Future?

Authors:  Rohan Dharmakumar
Journal:  Circ Cardiovasc Imaging       Date:  2017-12       Impact factor: 7.792

8.  Detection of acute reperfusion myocardial hemorrhage with cardiac MR imaging: T2 versus T2.

Authors:  Avinash Kali; Richard L Q Tang; Andreas Kumar; James K Min; Rohan Dharmakumar
Journal:  Radiology       Date:  2013-07-11       Impact factor: 11.105

Review 9.  Hybrid PET/MR imaging in myocardial inflammation post-myocardial infarction.

Authors:  B Wilk; G Wisenberg; R Dharmakumar; J D Thiessen; D E Goldhawk; F S Prato
Journal:  J Nucl Cardiol       Date:  2019-12-03       Impact factor: 5.952

Review 10.  Cardiovascular Magnetic Resonance in Acute ST-Segment-Elevation Myocardial Infarction: Recent Advances, Controversies, and Future Directions.

Authors:  Heerajnarain Bulluck; Rohan Dharmakumar; Andrew E Arai; Colin Berry; Derek J Hausenloy
Journal:  Circulation       Date:  2018-05-01       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.